Generate a tailored SOP for Dr. Jeffrey Crawford. Improve your application with a focused, well-structured draft.
Jeffrey Crawford is the George Barth Geller Distinguished Professor of Research in Cancer at Duke Cancer Institute. His research primarily focuses on lung cancer and innovative treatment approaches. He has led multiple multicenter randomized trials, including the pivotal trials on Filgrastim (G-CSF, Neupogen) and Vinorelbine (Navelbine), which both received FDA approval. His interests also extend to the development of treatment strategies for elderly patients with cancer and the evaluation of supportive care measures. As a principal investigator, he has conducted clinical trials concerning novel hematopoietic growth factors, such as stem cell factor and megakaryocyte growth development factor. Crawford's contributions to cancer research and medicine have significantly advanced therapeutic strategies for lung cancer, improving patient outcomes.
Duke Cancer Institute • Durham, NC
Leading cancer research with a focus on lung cancer and treatment methodologies.
Duke Cancer Institute • Durham, NC
Instructing and mentoring medical students and contributing to clinical research in oncology.
Duke Cancer Institute • Durham, NC
Conducting research and clinical trials on various cancer treatments.
Department of Biomedical Engineering (MS program)